Prostatic fibrosis, lower urinary tract symptoms, and BPH

被引：0
|
作者：
Jose A. Rodriguez-Nieves
Jill A. Macoska
机构：
[1] Program in Cellular and Molecular Biology,Department of Biology
[2] The University of Michigan,undefined
[3] The University of Massachusetts,undefined
来源：
Nature Reviews Urology | 2013年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this Perspectives article, Rodriguez-Nieves and Macoska discuss relationships between prostatic tissue inflammation (from ageing, infection, or other inflammatory disease processes), prostatic tissue fibrosis, lower urinary tract dysfunction (LUTD), and BPH, as well as highlighting recent advances in the use of antifibrotic therapeutic agents for treating LUTD.
引用
收藏
页码：546 / 550
页数：4
相关论文
共 50 条
  • [31] Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, and Urinary Retention
    Alawamlh, Omar Al Hussein
    Goueli, Ramy
    Lee, Richard K.
    MEDICAL CLINICS OF NORTH AMERICA, 2018, 102 (02) : 301 - +
  • [32] Measuring resistance index in patients with BPH and lower urinary tract symptoms
    Ozdemir, H
    Onur, R
    Bozgeyik, Z
    Orhan, I
    Ogras, MS
    Ogur, E
    JOURNAL OF CLINICAL ULTRASOUND, 2005, 33 (04) : 176 - 180
  • [33] Effects of obesity on lower urinary tract symptoms in Korean BPH patients
    Lee, Seung Hwan
    Kim, Joon Chul
    Lee, Ji-Youl
    Kim, Jang Hwan
    Oh, Cheol Young
    Lee, Seung Wook
    Yoo, Se Jeong
    Chung, Byung Ha
    ASIAN JOURNAL OF ANDROLOGY, 2009, 11 (06) : 663 - 668
  • [34] Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms Reply
    Sarma, Aruna V.
    Wei, John T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (17): : 1668 - 1669
  • [35] Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity
    McVary K.T.
    Mongiu A.K.
    Current Urology Reports, 2009, 10 (4) : 247 - 253
  • [36] Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms
    McNicholas, Tom
    Kirby, Roger
    AMERICAN FAMILY PHYSICIAN, 2012, 86 (04) : 359 - 360
  • [37] Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)
    Di Silverio, F
    Bosman, C
    Salvatori, M
    Albanesi, L
    Pannunzi, LP
    Ciccariello, M
    Cardi, A
    Salvatori, G
    Sciarra, A
    EUROPEAN UROLOGY, 2005, 47 (01) : 72 - 79
  • [38] Integrating the patient risk profile in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
    Artibani, W
    EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (04) : 1 - 6
  • [39] Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
    Gross, AJ
    Busse, M
    Leonard, J
    Schumacher, H
    PROSTATE CANCER AND PROSTATIC DISEASES, 2005, 8 (03) : 210 - 214
  • [40] Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
    A J Gross
    M Busse
    J Leonard
    H Schumacher
    Prostate Cancer and Prostatic Diseases, 2005, 8 : 210 - 214
12345